Skip to main content
Tech.euFundingExplorerBeta

Healthtech funding in H2 2024

European Healthtech startup funding raised during H2 2024.

In H2 2024, 200 European Healthtech companies closed 202 funding rounds and raised €2.9B in equity funding (excluding debt and grants), down 36.2% versus H2 2023. Debt rounds added €40M. UK led by capital raised, and High-Tech Gründerfonds (HTGF) was the most active investor. Data as of 20 Nov 2026.

Equity funding
€2.9B
-36.2% vs H2 2023 · excl. debt & grants · +€40M debt
Funding rounds
202
-10.6% vs H2 2023
Companies
200
Top country
UK
Rank among sectors
#3
11.6% of sector funding
Debt financing
€40M
1.4% of total
Top-10 round share
44.2%
of disclosed capital
Rounds ≥ €100M
4

Funding by month

€ raised vs rounds, by month
Healthtech — funding by month, H2 2024 — interactive chart.
Data table
FundingRounds
Jul€425M31
Aug€364M25
Sep€367M39
Oct€431M27
Nov€407M40
Dec€916M40

Top countries

by € raised
Healthtech — top countries by capital, H2 2024 — interactive chart.
Data table
Healthtech — top countries by capital, H2 2024
UK€907M
Switzerland€491M
Germany€362M
Finland€271M
France€231M
Netherlands€197M
Belgium€136M
Denmark€110M

Stage mix

by € raised
Healthtech — stage mix, H2 2024 — interactive chart.
Data table
Healthtech — stage mix, H2 2024
Other€887M
Series D+€553M
Series B€468M
Series C€405M
Series A€380M
Seed€147M
Debt€40M
Pre-Seed€17M
Grant€13M

Exits & M&A

8 Acquisition · 2 Merger

11 exits · €50M disclosed.

Lamidey Noury MedicalAcquisitionNov 2024€50M

Top deals

largest disclosed rounds in H2 2024
CompanyStageDateAmount
Cimeio TherapeuticsOtherDec 2024€282M
ŌURASeries D+Dec 2024€192M
Flo HealthSeries CJul 2024€185M
CaresyntaxSeries CAug 2024€164M
CitryllSeries BDec 2024€85M
Agomab TherapeuticsSeries D+Oct 2024€83M
Antag TherapeuticsSeries ADec 2024€80M
HumaSeries D+Jul 2024€73M
ŌURASeries D+Nov 2024€71M
CradleSeries BNov 2024€69M
NucleraSeries AOct 2024€69M
Neo MedicalOtherSep 2024€61M
Oxford Nanopore TechnologiesOtherAug 2024€59M
Quanta Dialysis TechnologiesSeries D+Nov 2024€57M
Basecamp ResearchSeries BOct 2024€55M

Top investors

most active in H2 2024, by deal count